A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1.

MLA

Ming, Jie, et al. “A Novel Chemical, STF-083010, Reverses Tamoxifen-Related Drug Resistance in Breast Cancer by Inhibiting IRE1/XBP1.” Oncotarget, vol. 6, no. 38, Dec. 2015, pp. 40692–703. EBSCOhost, https://doi.org/10.18632/oncotarget.5827.

APA

Ming, J., Ruan, S., Wang, M., Ye, D., Fan, N., Meng, Q., Tian, B., & Huang, T. (2015). A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1. Oncotarget, 6(38), 40692–40703. https://doi.org/10.18632/oncotarget.5827

Chicago

Ming, Jie, Shengnan Ruan, Mengyi Wang, Dan Ye, Ningning Fan, Qingyu Meng, Bo Tian, and Tao Huang. 2015. “A Novel Chemical, STF-083010, Reverses Tamoxifen-Related Drug Resistance in Breast Cancer by Inhibiting IRE1/XBP1.” Oncotarget 6 (38): 40692–703. doi:10.18632/oncotarget.5827.